Literature DB >> 21079169

Effect of apolactoferrin on experimental pneumococcal otitis media.

Patricia A Schachern1, Vladimir Tsuprun, Sebahatin Cureoglu, Patricia A Ferrieri, David E Briles, Michael M Paparella, Steven K Juhn.   

Abstract

OBJECTIVE: To find the effect of apolactoferrin administration on the middle and inner ears after experimentally induced pneumococcal otitis media.
DESIGN: Histopathologic and morphometric analysis of the middle and inner ears.
SETTING: University of Minnesota, Minneapolis.
SUBJECTS: Ten chinchillas.
INTERVENTIONS: The middle ear cavities of chinchillas were inoculated bilaterally with type 2 wild-type Streptococcus pneumoniae. Twenty-four hours later, the ears of 5 of the animals were injected with phosphate-buffered saline (PBS) and the other 5 with human apolactoferrin. The animals were killed 24 hours after the last injection. Bacterial counts were made of the middle ear effusions, and the cochleae were processed for histologic analysis. The thickness of the round window membranes and bacterial and inflammatory cell infiltration of the round window membranes, and scala tympani and damage of the hair cells and stria vascularis were compared for these 2 groups of animals. MAIN OUTCOME MEASURES: Comparison of inflammatory and bacterial cells in the middle and inner ears, and damage to inner ear structures.
RESULTS: Bacterial plate counts of middle ear effusions (P  = .005) and the number of inflammatory cells in the round window membrane (P  = .047) were significantly lower in the apolactoferrin group compared with the group treated with PBS.
CONCLUSION: Further investigation of apolactoferrin as a nonantibiotic approach for the treatment of otitis media and its complications is needed to confirm its safety and efficacy.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21079169      PMCID: PMC4022344          DOI: 10.1001/archoto.2010.192

Source DB:  PubMed          Journal:  Arch Otolaryngol Head Neck Surg        ISSN: 0886-4470


  21 in total

1.  Pneumococcal surface protein A inhibits complement activation by Streptococcus pneumoniae.

Authors:  A H Tu; R L Fulgham; M A McCrory; D E Briles; A J Szalai
Journal:  Infect Immun       Date:  1999-09       Impact factor: 3.441

Review 2.  Multifunctional roles of lactoferrin: a critical overview.

Authors:  P P Ward; E Paz; O M Conneely
Journal:  Cell Mol Life Sci       Date:  2005-11       Impact factor: 9.261

3.  Development of secretory elements in murine tubotympanum: lysozyme and lactoferrin immunohistochemistry.

Authors:  K Park; D J Lim
Journal:  Ann Otol Rhinol Laryngol       Date:  1993-05       Impact factor: 1.547

4.  Epidemiology of otitis media during the first seven years of life in children in greater Boston: a prospective, cohort study.

Authors:  D W Teele; J O Klein; B Rosner
Journal:  J Infect Dis       Date:  1989-07       Impact factor: 5.226

5.  Intranasal immunization of mice with PspA (pneumococcal surface protein A) can prevent intranasal carriage, pulmonary infection, and sepsis with Streptococcus pneumoniae.

Authors:  H Y Wu; M H Nahm; Y Guo; M W Russell; D E Briles
Journal:  J Infect Dis       Date:  1997-04       Impact factor: 5.226

Review 6.  Streptococcus pneumoniae: does antimicrobial resistance matter?

Authors:  Joseph P Lynch; George G Zhanel
Journal:  Semin Respir Crit Care Med       Date:  2009-03-18       Impact factor: 3.119

7.  Virulence of pneumococcal proteins on the inner ear.

Authors:  Patricia A Schachern; Vladimir Tsuprun; Sebahattin Cureoglu; Patricia Ferrieri; David E Briles; Michael M Paparella; Steven Juhn
Journal:  Arch Otolaryngol Head Neck Surg       Date:  2009-07

8.  Invasive pneumococcal disease caused by nonvaccine serotypes among alaska native children with high levels of 7-valent pneumococcal conjugate vaccine coverage.

Authors:  Rosalyn J Singleton; Thomas W Hennessy; Lisa R Bulkow; Laura L Hammitt; Tammy Zulz; Debby A Hurlburt; Jay C Butler; Karen Rudolph; Alan Parkinson
Journal:  JAMA       Date:  2007-04-25       Impact factor: 56.272

9.  The round window membrane in otitis media: effect of pneumococcal proteins.

Authors:  Patricia Schachern; Vladimir Tsuprun; Sebahattin Cureoglu; Patricia Ferrieri; David Briles; Michael Paparella; Steven Juhn
Journal:  Arch Otolaryngol Head Neck Surg       Date:  2008-06

10.  Safety and tolerability of the antimicrobial peptide human lactoferrin 1-11 (hLF1-11).

Authors:  Walter J F M van der Velden; Thijs M P van Iersel; Nicole M A Blijlevens; J Peter Donnelly
Journal:  BMC Med       Date:  2009-09-08       Impact factor: 8.775

View more
  4 in total

Review 1.  Role of innate immunity in the pathogenesis of otitis media.

Authors:  Rahul Mittal; Joyson Kodiyan; Robert Gerring; Kalai Mathee; Jian-Dong Li; M'hamed Grati; Xue Zhong Liu
Journal:  Int J Infect Dis       Date:  2014-11-05       Impact factor: 3.623

2.  Three-Dimensional Analysis of Round Window Membrane in the Chinchilla Model with Acute Otitis Media Induced with Streptococcus Pneumoniae 7F.

Authors:  Nevra Keskin Yılmaz; Hasan Albasan; Mehmet Kazım Börkü; Michael Mauro Paparella; Sebahattin Cüreoğlu
Journal:  Turk Arch Otorhinolaryngol       Date:  2021-03-26

Review 3.  Panel 4: Recent advances in otitis media in molecular biology, biochemistry, genetics, and animal models.

Authors:  Jian-Dong Li; Ann Hermansson; Allen F Ryan; Lauren O Bakaletz; Steve D Brown; Michael T Cheeseman; Steven K Juhn; Timothy T K Jung; David J Lim; Jae Hyang Lim; Jizhen Lin; Sung-Kyun Moon; J Christopher Post
Journal:  Otolaryngol Head Neck Surg       Date:  2013-04       Impact factor: 3.497

4.  An in vitro model of murine middle ear epithelium.

Authors:  Apoorva Mulay; Khondoker M Akram; Debbie Williams; Hannah Armes; Catherine Russell; Derek Hood; Stuart Armstrong; James P Stewart; Steve D M Brown; Lynne Bingle; Colin D Bingle
Journal:  Dis Model Mech       Date:  2016-09-22       Impact factor: 5.758

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.